Brief: Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
14/08/2025 11:27
Aug 14 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES $75M STRATEGIC FUNDING AGREEMENT WITH RTW TO SUPPORT THE POTENTIAL LAUNCH OF ANAPHYLM™ (EPINEPHRINE) SUBLINGUAL FILM Source text: ID:nGNXZwjM6 Further company coverage: AQST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma